161 related articles for article (PubMed ID: 35608226)
1. The prognosis of elderly patients with hepatocellular carcinoma: A multi-center 19-year experience in Japan.
Hatanaka T; Kakizaki S; Hiraoka A; Kariyama K; Tsuji K; Ishikawa T; Toyoda H; Yasuda S; Naganuma A; Tada T; Takaguchi K; Tsutsui A; Itobayashi E; Shimada N; Shibata H; Tanaka T; Nagano T; Imai M; Nakamura S; Nouso K; Kosaka H; Kaibori M; Kumada T;
Cancer Med; 2023 Jan; 12(1):345-357. PubMed ID: 35608226
[TBL] [Abstract][Full Text] [Related]
2. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.
Ma XL; Zhou JY; Gao XH; Tian L; Wu J; Zhang CY; Zhou Y; Dai Q; Wang BL; Pan BS; Yang XR; Guo W
Clin Chim Acta; 2016 Nov; 462():15-22. PubMed ID: 27520748
[TBL] [Abstract][Full Text] [Related]
3. Optimal treatment strategy for elderly patients with hepatocellular carcinoma.
Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
J Gastroenterol Hepatol; 2004 Aug; 19(8):859-65. PubMed ID: 15242487
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in Keio affiliated hospitals--diagnosis, treatment, and prognosis of this disease.
Saito H; Masuda T; Tada S; Ebinuma H; Yamagishi Y; Ojiro K; Inoue M; Hibi T
Keio J Med; 2009 Sep; 58(3):161-75. PubMed ID: 19826210
[TBL] [Abstract][Full Text] [Related]
5. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
Kim NG; Nguyen PP; Dang H; Kumari R; Garcia G; Esquivel CO; Nguyen MH
Cancer; 2018 Jun; 124(12):2588-2598. PubMed ID: 29624631
[TBL] [Abstract][Full Text] [Related]
6. The Role of the Albumin-Bilirubin Score for Predicting the Outcomes in Japanese Patients with Advanced Hepatocellular Carcinoma Treated with Ramucirumab: A Real-World Study.
Hatanaka T; Naganuma A; Shibasaki M; Kohga T; Arai Y; Nagashima T; Ueno T; Namikawa M; Saito S; Hoshino T; Takizawa D; Arai H; Makita F; Kakizaki S; Harimoto N; Shirabe K; Uraoka T
Oncology; 2021; 99(4):203-214. PubMed ID: 33279908
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
[TBL] [Abstract][Full Text] [Related]
8. Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.
Zhang L; Sun JH; Hou ZH; Zhong BY; Yang MJ; Zhou GH; Wang WS; Huang P; Zhang S; Li Z; Zhu XL; Yan ZP; Ni CF
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):63-72. PubMed ID: 32965582
[TBL] [Abstract][Full Text] [Related]
9. The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma.
Pinato DJ; Sharma R; Citti C; Platt H; Ventura-Cots M; Allara E; Chen TY; Dalla Pria A; Jain M; Mínguez B; Kikuchi L; Kaufman West E; Merli M; Kaplan DE; Hasson H; Marks K; Nelson M; Núñez M; Aytaman A; Bower M; Bräu N;
Aliment Pharmacol Ther; 2018 Jan; 47(1):95-103. PubMed ID: 29034998
[TBL] [Abstract][Full Text] [Related]
10. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.
Pinato DJ; Sharma R; Allara E; Yen C; Arizumi T; Kubota K; Bettinger D; Jang JW; Smirne C; Kim YW; Kudo M; Howell J; Ramaswami R; Burlone ME; Guerra V; Thimme R; Ishizuka M; Stebbing J; Pirisi M; Carr BI
J Hepatol; 2017 Feb; 66(2):338-346. PubMed ID: 27677714
[TBL] [Abstract][Full Text] [Related]
11. Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma.
Cohen MJ; Bloom AI; Barak O; Klimov A; Nesher T; Shouval D; Levi I; Shibolet O
World J Gastroenterol; 2013 Apr; 19(16):2521-8. PubMed ID: 23674854
[TBL] [Abstract][Full Text] [Related]
12. Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities.
Wehling C; Dill MT; Olkus A; Springfeld C; Chang DH; Naumann P; Longerich T; Kratochwil C; Mehrabi A; Merle U; Pfeiffenberger J; Rupp C; Weiss KH; Mieth M
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2471-2481. PubMed ID: 33537908
[TBL] [Abstract][Full Text] [Related]
13. [Hepatocellular carcinoma in the elderly: clinical characteristics, survival analysis, and prognostic indicators in a cohort of Spanish patients older than 75 years].
Fernández-Ruiz M; Guerra-Vales JM; Llenas-García J; Colina-Ruizdelgado F
Rev Esp Enferm Dig; 2008 Oct; 100(10):625-31. PubMed ID: 19119788
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance: potential implications for surveillance goal.
Song JH; Goh MJ; Park Y; Oh JH; Kang W; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Scand J Gastroenterol; 2021 Mar; 56(3):274-280. PubMed ID: 33399022
[TBL] [Abstract][Full Text] [Related]
15. Favorable Survival with Non-curative Treatments for Patients with Early-Stage Hepatocellular Carcinoma After Liver Transplant Denial.
Zori A; Villanueva F; Hatamleh D; Ismael M; Forde J; Mota M; Johnson L; Cabrera R
Dig Dis Sci; 2021 Feb; 66(2):628-635. PubMed ID: 32219612
[TBL] [Abstract][Full Text] [Related]
16. Improved Survival of Hepatocellular Carcinoma Patients Diagnosed with a Dedicated Screening Programme-a Propensity Score Adjusted Analysis.
Chinnaratha MA; Campbell K; Mathias R; McCormick RJ; Woodman RJ; Wigg AJ
J Gastrointest Cancer; 2019 Dec; 50(4):888-893. PubMed ID: 30345486
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
Kuo MJ; Mo LR; Chen CL
BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
[TBL] [Abstract][Full Text] [Related]
18. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma.
Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2016 Oct; 31(10):1766-1772. PubMed ID: 26992142
[TBL] [Abstract][Full Text] [Related]
19. Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study.
Kim BK; Kim DY; Han KH; Seong J
PLoS One; 2019; 14(10):e0223678. PubMed ID: 31622424
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
